GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

FHS
July 29, 2024
3:51 am

Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.

Biocon and Handok link for Liraglutide commercialisation

Biocon will handle Liraglutide’s development, manufacturing and supply. Credit: Poetra.RH / Shutterstock.com. Indian biopharmaceutical company Biocon has entered an exclusive licence and supply agreement with

May 24, 2024

CDC studies show effectiveness of flu vaccines across all age groups

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

February 19, 2024

Impact of early COVID-19 job loss on later mental health uncovered

How income or job loss during the initial phases of the coronavirus disease 2019 (COVID-19) pandemic is linked to subsequent psychological distress.

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.